Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedOct 2, 2019ZarontinLabeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be...Pfizer Inc. · D-0002-2020Class IIITerminatedOct 2, 2019ethosuximide capsulesLabeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be...Pfizer Inc. · D-0001-2020Class IITerminatedSep 25, 2019AllergyFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1874-2019Class IITerminatedSep 25, 2019Wal-FexFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1873-2019Class IITerminatedSep 25, 2019AllergyFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1872-2019Class IITerminatedSep 25, 2019Fexofenadine HCL Tablets USPFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1871-2019Class IITerminatedSep 25, 2019Fexofenadine Hydrochloride Tablets USPFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1870-2019Class IITerminatedSep 25, 2019Allergy ReliefFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1869-2019Class IITerminatedSep 25, 2019Fexofenadine Hydrochloride Tablets USPFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1868-2019Class IITerminatedSep 25, 2019fexofenadine hydrochloride tablets USPFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1867-2019Class IITerminatedSep 25, 2019Allergy ReliefFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1866-2019Class IITerminatedSep 25, 2019Allergy ReliefFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1865-2019Class IITerminatedSep 25, 2019Fexofenadine Hydrochrloride Tablets USPFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-1864-2019Class IITerminatedSep 25, 2019Oxcarbazepine Oral SuspensionFailed Impurities/Degradation SpecificattionWest-Ward Columbus Inc · D-1863-2019Class IITerminatedSep 25, 2019Anagrelide CapsulesFailed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.Torrent Pharma Inc. · D-1862-2019Class IITerminatedSep 25, 2019Soothing Sore ReliefSuperpotent Drug: products were found to be contaminated and above specification for lidocaine assay.Ridge Properties, LLC · D-1861-2019Class IITerminatedSep 25, 2019Soothing Sore ReliefSuperpotent Drug: products were found to be contaminated and above specification for lidocaine assay.Ridge Properties, LLC · D-1860-2019Class IITerminatedSep 25, 2019Superior Pain & Itch ReliefSuperpotent Drug: products were found to be contaminated and above specification for lidocaine assay.Ridge Properties, LLC · D-1859-2019Class IITerminatedSep 25, 2019Superior Pain & Itch ReliefSuperpotent Drug: products were found to be contaminated and above specification for lidocaine assay.Ridge Properties, LLC · D-1858-2019Class IITerminatedSep 25, 2019PRE-TATMicrobial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.Ridge Properties, LLC · D-1857-2019Class IITerminatedSep 25, 2019PRE-TATMicrobial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.Ridge Properties, LLC · D-1856-2019Class ITerminatedSep 18, 2019Milk of Magnesia USPMicrobial Contamination of Non-Sterile Products: product failed bioburden testing for Total Aerobic Microbial Count.Plastikon Healthcare LLC · D-1879-2019Class IITerminatedSep 18, 2019AVKARE Fexofenadine Hydrochloride Tablets USP Antihistamine 180 mgFailed Stability Specifications.AVKARE Inc. · D-1875-2019Class IITerminatedSep 18, 20195% Acetyl-L-Cysteine Ophthalmic SolutionsLack of Processing Controls:Compounded Solutions in Pharmacy · D-1855-2019Class IITerminatedSep 18, 201910% Acetyl-L-Cysteine Ophthalmic SolutionsLack of Processing Controls:Compounded Solutions in Pharmacy · D-1854-2019Class IITerminatedSep 18, 201920% Acetyl-L-Cysteine Ophthalmic SolutionsLack of Processing Controls:Compounded Solutions in Pharmacy · D-1853-2019Class IITerminatedSep 18, 2019Bacteriostatic Water for InjectionLack of Assurance of SterilityPfizer Inc. · D-1852-2019Class IIITerminatedSep 18, 2019Pramipexole Dihydrochloride Tablets 0.125 mgSubpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mgMacleods Pharma Usa Inc · D-1851-2019Class IITerminatedSep 18, 2019BevacizumabLack of assurance of sterility.Pacifico National, Inc. dba AmEx Pharmacy · D-1850-2019Class IITerminatedSep 18, 2019BevacizumabLack of assurance of sterility.Pacifico National, Inc. dba AmEx Pharmacy · D-1849-2019Class IIITerminatedSep 18, 2019Gatifloxacin Ophthalmic Solution 0.5%Failed Impurities/Degradation Specifications:OOS for unknown impurity.Mylan Pharmaceuticals Inc. · D-1848-2019Class IIITerminatedSep 18, 2019Lamivudine TabletsLabeling: Incorrect or Missing Package Insert; an error in the Dosage Forms and Strengths section of the insert that incorrectly lists the tablet description coding for...American Health Packaging · D-1847-2019Class IITerminatedSep 4, 2019VivitrolLabeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration...Alkermes Inc · D-1846-2019Class IITerminatedSep 4, 2019RELPAX (eletriptan HBr) tabletsMicrobial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.Pfizer Inc. · D-1845-2019Class IIITerminatedSep 4, 2019Simvastatin TabletsLabeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034BAurobindo Pharma USA Inc. · D-1842-2019Class IIITerminatedSep 4, 2019Eptifibatide InjectionFailed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.Akorn, Inc. · D-1841-2019Class IIITerminatedSep 4, 2019Eptifibatide InjectionShort Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification...Akorn, Inc. · D-1840-2019Class IIITerminatedSep 4, 2019Eptifibatide InjectionFailed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.Akorn, Inc. · D-1839-2019Class IITerminatedAug 28, 2019Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM UseLack of Assurance of Sterility.SCA Pharmaceuticals, LLC · D-1843-2019Class IITerminatedAug 28, 2019Bexarotene CapsulesFailed Dissolution SpecificationsUpsher Smith Laboratories, Inc. · D-1836-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.